3-hydroxyflavone has been researched along with Nervous System Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyina, HK; Kalakotla, S; Pasangulapati, JP; Perumal, V; Ravula, AR; Teegala, SB | 1 |
| Carradori, S; Cataldi, A; Elsallabi, O; Gallorini, M; Patruno, A; Pesce, M | 1 |
| Deng, P; Hao, D; He, Y; Jiang, C; Jiang, Y; Tang, X; Yang, H | 1 |
| Afaq, F; Pal, HC; Pearlman, RL | 1 |
| Andrés, AC; Carolina, E; Dajas, F; Felicia, RM; Florencia, A | 1 |
5 review(s) available for 3-hydroxyflavone and Nervous System Diseases
| Article | Year |
|---|---|
Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: An updated review.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Flavonols; Glycation End Products, Advanced; Glycolysis; Humans; Long-Term Potentiation; Memory; Nervous System Diseases; Oxidative Stress; Phosphorylation; Signal Transduction | 2021 |
Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection.
Topics: Animals; Antioxidants; Cellular Senescence; Flavonols; Humans; Nervous System Diseases; Neuroprotective Agents | 2022 |
The Neuroprotective Role of Fisetin in Different Neurological Diseases: a Systematic Review.
Topics: Flavonoids; Flavonols; Humans; Nervous System Diseases; Neuroprotection; Neuroprotective Agents; Quality of Life | 2023 |
Fisetin and Its Role in Chronic Diseases.
Topics: Animals; Chronic Disease; Diabetes Mellitus; Flavonoids; Flavonols; Humans; Nervous System Diseases; Obesity; Signal Transduction | 2016 |
Neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features.
Topics: Animals; Antioxidants; Flavones; Flavonoids; Flavonols; Humans; Nervous System Diseases; Neuroprotective Agents; Oxidative Stress; Structure-Activity Relationship | 2013 |